Last $30.81 USD
Change Today -0.99 / -3.11%
Volume 684.3K
WX On Other Exchanges
New York
As of 8:04 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

wuxi pharmatech cayman-adr (WX) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/25/14 - $40.72
52 Week Low
08/9/13 - $22.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

wuxi pharmatech cayman-adr (WX) Related Businessweek News

No Related Businessweek News Found

wuxi pharmatech cayman-adr (WX) Details

WuXi PharmaTech (Cayman) Inc. operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company in China and the United States. It operates in two segments, Laboratory Services and Manufacturing Services. The Laboratory Services segment offers services for small molecules, such as synthetic chemistry, biology, medicinal chemistry, DMPK/ADME, formulation, analytical chemistry, toxicology, clinical development, bioanalytical services, genomics, research reagent production, and clinical services, as well as services for discovery and development of biologics; and laboratory services, including testing services for biologics, medical devices, and combination products. The Manufacturing Services segment produces and manufactures advanced intermediates and active pharmaceutical ingredients for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and for commercial products, as well as produces biologics. The company sells its products directly to pharmaceutical, biotechnology, and medical device companies. Wuxi PharmaTech (Cayman) Inc. was founded in 2000 and is based in Shanghai, China.

7,445 Employees
Last Reported Date: 04/15/14
Founded in 2000

wuxi pharmatech cayman-adr (WX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

wuxi pharmatech cayman-adr (WX) Key Developments

Ying Han Step Down from the Board of Directors of WuXi PharmaTech

WuXi PharmaTech said that Ying Han has stepped down from the its Board of Directors for personal reasons. The company said that Han has served on its board since 2008. WuXi has begun a search for a new board member to complete Han's term of office. The audit committee, of which Han was chairman, is comprised of Kian-Wee Seah and Xuesong (Jeff) Leng, who have served on WuXi's board since 2005 and 2008, respectively.

Wuxi PharmaTech (Cayman) Inc. Announces Resignation of Ying Han to its Board of Directors

WuXi PharmaTech (Cayman) Inc. announced that Ying Han has stepped down from the WuXi Board of Directors for personal reasons. Ms. Han has served on WuXi's board since 2008.

WuXi PharmaTech (Cayman) Inc. Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 02:15 PM

WuXi PharmaTech (Cayman) Inc. Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 02:15 PM. Venue: Sheraton Hong Kong Hotel & Towers, 20 Nathan Road, Kowloon, Hong Kong. Speakers: Sofie Qiao, Managing Director WuXi Venture Fund.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WX:US $30.81 USD -0.99

WX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Charles River Laboratories International Inc $54.21 USD -1.70
Covance Inc $83.92 USD -1.47
Hangzhou Tigermed Consulting Co Ltd CNY30.95 CNY -0.06
ICON PLC $51.80 USD -0.31
PAREXEL International Corp $53.56 USD -1.22
View Industry Companies

Industry Analysis


Industry Average

Valuation WX Industry Range
Price/Earnings 21.0x
Price/Sales 3.9x
Price/Book 3.2x
Price/Cash Flow 20.8x
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WUXI PHARMATECH CAYMAN-ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at